These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11185467)

  • 1. Insulin-sensitizing agents and their effect on adrenal androgens.
    Unlühizarci K; Keleştimur F; Bayram F
    Fertil Steril; 2000 Nov; 74(5):1058-9. PubMed ID: 11185467
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
    Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome.
    Cheung AP; Chang RJ
    Clin Obstet Gynecol; 1990 Sep; 33(3):655-67. PubMed ID: 2225592
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
    Guido M; Romualdi D; Suriano R; Giuliani M; Costantini B; Apa R; Lanzone A
    Hum Reprod; 2004 Mar; 19(3):534-9. PubMed ID: 14998947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome--beyond ovulation induction.
    Stadtmauer LA; Wong BC; Oehninger S
    Hum Reprod; 2002 Dec; 17(12):3016-26. PubMed ID: 12456596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variability of the adrenal involvement in the polycystic ovary syndrome].
    Boccuzzi G
    Minerva Endocrinol; 1987; 12(3):213-6. PubMed ID: 2821374
    [No Abstract]   [Full Text] [Related]  

  • 8. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian, adrenal, and peripheral testosterone levels in the polycystic ovary syndrome.
    Stahl NL; Teeslink CR; Greenblatt RB
    Am J Obstet Gynecol; 1973 Sep; 117(2):194-200. PubMed ID: 4728868
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD; Strucchi C; Luisi M; Casarosa E; Lanzoni C; Baraldi E; Ricchieri F; Mehmeti H; Genazzani AR
    Gynecol Endocrinol; 2006 Jan; 22(1):36-43. PubMed ID: 16522532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].
    Pugeat M
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S25-9. PubMed ID: 12773915
    [No Abstract]   [Full Text] [Related]  

  • 15. Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations--introductory report.
    Marciniak A; Nawrocka-Rutkowska J; Brodowska A; Sienkiewicz R; Szydłowska I; Starczewski A
    Folia Histochem Cytobiol; 2009; 47(2):323-8. PubMed ID: 19995720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome.
    Carmina E; Gonzalez F; Vidali A; Stanczyk FZ; Ferin M; Lobo RA
    Hum Reprod; 1999 Feb; 14(2):307-11. PubMed ID: 10099969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
    Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and polycystic ovary syndrome.
    Lebinger TG
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):132-40. PubMed ID: 17940431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of polycystic ovary syndrome.
    Tsilchorozidou T; Overton C; Conway GS
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):1-17. PubMed ID: 14678281
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.